These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20097682

  • 1. Prevalence and pharmacological treatment of left-ventricular dysfunction in patients undergoing vascular surgery.
    Flu WJ, van Kuijk JP, Galal W, Kuiper R, van de Ven LL, Verhagen HJ, Bax JJ, Poldermans D.
    Eur J Heart Fail; 2010 Mar; 12(3):288-93. PubMed ID: 20097682
    [Abstract] [Full Text] [Related]

  • 2. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M, French National College of Cardiologists.
    Arch Cardiovasc Dis; 2012 Mar; 105(6-7):355-65. PubMed ID: 22800720
    [Abstract] [Full Text] [Related]

  • 3. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A, Aronow WS, Vadnerkar A, Sivan K, Mittal S.
    Am J Ther; 2009 Mar; 16(1):5-7. PubMed ID: 19142162
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic implications of asymptomatic left ventricular dysfunction in patients undergoing vascular surgery.
    Flu WJ, van Kuijk JP, Hoeks SE, Kuiper R, Schouten O, Goei D, Elhendy A, Verhagen HJ, Thomson IR, Bax JJ, Fleisher LA, Poldermans D.
    Anesthesiology; 2010 Jun; 112(6):1316-24. PubMed ID: 20502115
    [Abstract] [Full Text] [Related]

  • 6. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.
    Pacing Clin Electrophysiol; 2010 Jun 01; 33(6):696-704. PubMed ID: 20059719
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, Greenberg B, Klibaner MI, Kukin ML, Sugg JE, REVERT Study Group.
    Circulation; 2007 Jul 03; 116(1):49-56. PubMed ID: 17576868
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
    Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B, Heidenreich PA, Knabel T, Konstam MA, Steimle A, Warner Stevenson L.
    J Am Coll Cardiol; 2003 May 07; 41(9):1529-38. PubMed ID: 12742294
    [Abstract] [Full Text] [Related]

  • 14. Significance of left ventricular diastolic function on outcomes after surgical ventricular restoration.
    Marui A, Nishina T, Saji Y, Yamazaki K, Shimamoto T, Ikeda T, Sakata R.
    Ann Thorac Surg; 2010 May 07; 89(5):1524-31. PubMed ID: 20417772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE.
    Eur J Heart Fail; 2015 Apr 07; 17(4):442-52. PubMed ID: 25727879
    [Abstract] [Full Text] [Related]

  • 18. Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.
    Thune JJ, Køber L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, Ghali JK, Arnold JM, Velazquez EJ, Solomon SD.
    J Am Soc Echocardiogr; 2006 Dec 07; 19(12):1462-5. PubMed ID: 17138030
    [Abstract] [Full Text] [Related]

  • 19. American College of Cardiology/American Heart Association Chronic Heart Failure Evaluation and Management guidelines: relevance to the geriatric practice.
    Ahmed A.
    J Am Geriatr Soc; 2003 Jan 07; 51(1):123-6. PubMed ID: 12534856
    [Abstract] [Full Text] [Related]

  • 20. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.
    de Groote P, Fertin M, Duva Pentiah A, Goéminne C, Lamblin N, Bauters C.
    Circ Heart Fail; 2014 May 07; 7(3):434-9. PubMed ID: 24563449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.